Subjects: Blood Transfusion and United States. Food and Drug Administration. / Genre: Technical Report - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Blood Transfusion ✖ Subjects United States. Food and Drug Administration. ✖ Genre Technical Report ✖

1. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, July 2018
Subject(s):: Blood Component Transfusion
Blood Safety -- standards
Blood Transfusion
Zika Virus Infection -- blood
Zika Virus Infection -- transmission
Blood Donors
Zika Virus Infection -- epidemiology
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

2. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, December 2017
Subject(s):: Blood Donors
Donor Selection -- standards
Hepacivirus
Hepatitis C -- blood
HIV Infections -- blood
HIV-1
RNA, Viral -- blood
Blood -- virology
Blood Transfusion
Disease Transmission, Infectious -- prevention & control
Nucleic Acid Amplification Techniques
Polymerase Chain Reaction
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

3. Recommendations to reduce the possible risk of transmission of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease by blood and blood components

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, August 2020
Subject(s):: Blood Donors
Blood Transfusion
Creutzfeldt-Jakob Syndrome -- prevention & control
Creutzfeldt-Jakob Syndrome -- transmission
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

4. Revised recommendations for reducing the risk of human immunodeficiency virus transmission by blood and blood products

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, August 2020
Subject(s):: Blood Donors
Blood Transfusion
HIV
HIV Infections -- prevention & control
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

5. Revised recommendations to reduce the risk of transfusion-transmitted malaria

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, April 2020
Subject(s):: Blood Donors
Blood Transfusion
Malaria -- prevention & control
Malaria -- transmission
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

6. Alternative procedures for blood and blood components during the COVID-19 public health emergency

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, April 2020
Subject(s):: Blood Donors
Blood Transfusion
Plasma
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

7. Recommendations for reducing the risk of transfusion-transmitted babesiosis

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, May 2019
Subject(s):: Babesiosis -- transmission
Blood Transfusion
Disease Transmission, Infectious -- prevention & control
Donor Selection -- standards
Babesiosis -- prevention & control
Blood -- microbiology
Surveys and Questionnaires
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.